EUVIMEDEUVIMED entdecken
Crossref

Cholecalciferol therapy; is it the gold standard for vitamin D deficiency and mineral disorders in hemodialysis?

Mouna Jerbi, Hiba Ghabi, Hanene Gaied, Fathi Ben Hmida, Raja Aoudia, Rim Goucha, Taieb Ben Abdallah

Journal of Renal Endocrinology · 2020

DOI: 10.34172/jre.2021.09 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Renal Endocrinology, 2020. Verfasst von Mouna Jerbi und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Vitamin D deficiency is frequently observed among dialysis patients. Previous studies suggested that 50 to 90% of end-stage renal disease patients are deficient in vitamin D. In Tunisia, studies regarding hypovitaminosis D in patients on dialysis are not numerous. Actually, many data support the use of native vitamin D in hemodialysis (HD) patients. In Tunisia, using native vitamin D is not part of therapeutic habits of all dialysis centers.

Objectives

The aim of this study was to determine the prevalence of vitamin D deficiency in patients with chronic kidney disease stage 5 undergoing HD and to evaluate the effect of oral cholecalciferol supplementation, in intact parathormone (iPTH), serum calcium and serum phosphorus. Patients and Methods: We conducted a pre-experimental study among HD patients. Monthly oral supplementation with Cholecalciferol, was instituted for six months.

Results

Forty-three participants were included. The mean 25-hydroxy vitamin D concentration was 17.89 ng/mL. Vitamin D deficiency was observed in 83.7% of our patients. We observed a significant increase in 25-hydroxy vitamin D and calcium levels and a significant decline in iPTH levels. No evidence of toxicity, nor severe hypercalcemia or hyperphosphatemia was noted.

Conclusion

The supplementation with cholecalciferol seems reasonable and well tolerated in HD patients if reasonable doses are used with regular monitoring.

Zitieren

APA

Jerbi, M., Ghabi, H., Gaied, H., Hmida, F. B., Aoudia, R., Goucha, R., & Abdallah, T. B. (2020). Cholecalciferol therapy; is it the gold standard for vitamin D deficiency and mineral disorders in hemodialysis?. Journal of Renal Endocrinology. https://doi.org/10.34172/jre.2021.09

Vancouver

Jerbi M, Ghabi H, Gaied H, Hmida FB, Aoudia R, Goucha R, et al. Cholecalciferol therapy; is it the gold standard for vitamin D deficiency and mineral disorders in hemodialysis?. Journal of Renal Endocrinology. 2020. doi:10.34172/jre.2021.09

BibTeX
@article{Jerbi2020,
  author = {Jerbi, Mouna and Ghabi, Hiba and Gaied, Hanene and Hmida, Fathi Ben and Aoudia, Raja and Goucha, Rim and Abdallah, Taieb Ben},
  title = {Cholecalciferol therapy; is it the gold standard for vitamin D deficiency and mineral disorders in hemodialysis?},
  journal = {Journal of Renal Endocrinology},
  year = {2020},
  doi = {10.34172/jre.2021.09}
}
Kostenlos starten →